These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37202205)

  • 1. [Cardiac magnetic resonance-feature tracking technique can assess cardiac function and prognosis in patients with myocardial amyloidosis].
    Cui J; Li R; Liu X; Zhao Y; Zhang X; Liu Q; Li T
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):660-666. PubMed ID: 37202205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of left ventricular global and segmental strain parameters by cardiovascular magnetic resonance tissue tracking in light-chain cardiac amyloidosis and hypertrophic cardiomyopathy.
    Wang F; Xu X; Wang Q; Yu D; Lv L; Wang Q
    Quant Imaging Med Surg; 2023 Jan; 13(1):449-461. PubMed ID: 36620161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
    Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Magnetic Resonance Imaging Tissue Feature Tracking for Cardiac Amyloidosis].
    Wang ZT; Wang CH; Chen YS; Sun JY; Zhu T; Zhang Y; Gao FB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 50(4):466-470. PubMed ID: 31642220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy.
    Cavus E; Muellerleile K; Schellert S; Schneider J; Tahir E; Chevalier C; Jahnke C; Radunski UK; Adam G; Kirchhof P; Blankenberg S; Lund GK; Avanesov M; Patten M
    Clin Res Cardiol; 2021 Nov; 110(11):1757-1769. PubMed ID: 33779809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced myocardial characterization in hypertrophic cardiomyopathy: feasibility of CMR-based feature tracking strain analysis in a case-control study.
    Yang L; Zhang L; Cao S; Gao C; Xu H; Song T; Zhang X; Wang K
    Eur Radiol; 2020 Nov; 30(11):6118-6128. PubMed ID: 32588208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-parametric non-contrast cardiac magnetic resonance for the differentiation between cardiac amyloidosis and hypertrophic cardiomyopathy.
    Steen H; Montenbruck M; Kallifatidis A; André F; Frey N; Kelle S; Korosoglou G
    Clin Res Cardiol; 2024 Mar; 113(3):469-480. PubMed ID: 38095711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional significance of myocardial activity at
    Zhang Y; Dong Z; Wang L; Wang YL; Chen BX; Su Y; Zhao S; Yang MF
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):110-122. PubMed ID: 37642705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of tissue tracking assessment by cardiovascular magnetic resonance for cardiac amyloidosis and hypertrophic cardiomyopathy.
    Jung HN; Kim SM; Lee JH; Kim Y; Lee SC; Jeon ES; Yong HS; Choe YH
    Acta Radiol; 2020 Jul; 61(7):885-893. PubMed ID: 31684748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study.
    Negri F; Muser D; Driussi M; Sanna GD; Masè M; Cittar M; Poli S; De Bellis A; Fabris E; Puppato M; Grigoratos C; Todiere G; Aquaro GD; Sinagra G; Imazio M
    Int J Cardiol; 2021 Dec; 345():61-67. PubMed ID: 34728259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.
    Hinojar R; Fernández-Golfín C; González-Gómez A; Rincón LM; Plaza-Martin M; Casas E; García-Martín A; Fernandez-Mendez MA; Esteban A; Nacher JJJ; Zamorano JL
    Int J Cardiol; 2017 Dec; 249():467-472. PubMed ID: 29121751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnostic and prognostic value of myocardial strain derived from cardiovascular magnetic resonance in patients with cardiac amyloidosis.
    Hou W; Wang Z; Huang J; Fan F; Yang F; Qiu L; Zhao K; Qiu J; Yang Y; Ma W; Gong Y; Hong T
    Cardiovasc Diagn Ther; 2023 Dec; 13(6):979-993. PubMed ID: 38162105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of cardiac magnetic resonance imaging parameters in left ventricular noncompaction with left ventricular dysfunction.
    Bai W; Xu R; Li X; Xu H; Fu H; Hou R; Zhou Z; Huang W; Wang Y; Guo Y
    BMC Cardiovasc Disord; 2022 Dec; 22(1):526. PubMed ID: 36474142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstructive and Nonobstructive Hypertrophic Cardiomyopathy: Differences in Global and Segmental Myocardial Strain by Cardiac Magnetic Resonance Feature Tracking.
    Palmisano V; Cossa S; Esposito A; Bassareo PP; Porcu M; Cau R; Pontone G; Suri JS; Saba L
    J Thorac Imaging; 2022 Jan; 37(1):49-57. PubMed ID: 34387228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers.
    Negri F; Sanna GD; Di Giovanna G; Cittar M; Grilli G; De Luca A; Dal Ferro M; Baracchini N; Burelli M; Paldino A; Del Franco A; Pradella S; Todiere G; Olivotto I; Imazio M; Sinagra G; Merlo M
    Circ Cardiovasc Imaging; 2024 Apr; 17(4):e016042. PubMed ID: 38563190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial extracellular volume quantification in cardiac amyloidosis: a comparative study between cardiac computed tomography and magnetic resonance imaging.
    Hayashi H; Oda S; Kidoh M; Yamaguchi S; Yoshimura F; Takashio S; Usuku H; Nagayama Y; Nakaura T; Ueda M; Tsujita K; Hirai T
    Eur Radiol; 2024 Feb; 34(2):1016-1025. PubMed ID: 37597032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional Analysis of Myocardial Strain to Wall Thickness Ratio in Cardiac Amyloidosis and Hypertrophic Cardiomyopathy.
    Gannon MP; Sison CP; Saba SG
    J Thorac Imaging; 2024 Jul; 39(4):255-264. PubMed ID: 38193208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy.
    Dohy Z; Szabo L; Toth A; Czimbalmos C; Horvath R; Horvath V; Suhai FI; Geller L; Merkely B; Vago H
    Int J Cardiovasc Imaging; 2021 Jun; 37(6):2027-2036. PubMed ID: 33555536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Cardiovascular Magnetic Resonance-Derived Myocardial Strain Analysis Provides Independent Prognostic Value in Acute Myocarditis.
    Vos JL; Raafs AG; van der Velde N; Germans T; Biesbroek PS; Roes K; Hirsch A; Heymans SRB; Nijveldt R
    J Am Heart Assoc; 2022 Oct; 11(19):e025106. PubMed ID: 36129042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.